Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase II clinical trial evaluating QLS12010 capsules in adults with moderate-to-severe atopic dermatitis is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Methotrexat to Hand Eczema in the BIOSKIN Cohort
The BIOSKIN cohort is evaluating methotrexate for hand eczema in patients with atopic dermatitis and contact dermatitis, with the study curr…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis [NA]
A clinical trial investigates whether retaining vernix caseosa in newborns could help prevent atopic dermatitis, and the study status is not…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application). [NA]
An exploratory clinical investigation using an EEG headband to assess neurosensory responses in adults with mild to moderate atopic dermatit…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy [Phase 3]
Phase 3 trial evaluating tralokinumab for moderate-to-severe atopic hand eczema has completed. The study, sponsored by LEO Pharma, aimed to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis [NA]
This is a clinical trial update for a birth-cohort study examining the development of IgE autoantibodies in newborns at high risk of Atopic …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Study for HSK44459 in Participants With Atopic Dermatitis [Phase 2]
This clinical trial update describes a Phase 2 study of HSK44459 for atopic dermatitis, with the trial currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of oral roflumilast for moderate to severe atopic dermatitis in patients aged 12…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
This clinical trial update indicates ongoing recruitment for a University of Pittsburgh study collecting blood, urine, and tissue samples fr…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum [NA]
The update covers a completed clinical trial examining the role of staphylococcal toxins in atopic dermatitis and eczema herpeticum. Sponsor…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: URGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis [NA]
Clinical trial update indicating URGO FilmoCream Eczema + Dermocorticoids for Atopic Dermatitis is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Frequency of Palpebral Involvement in Adult With Atopic Dermatitis
A clinical trial is investigating how often the palpebral (eyelid) area is involved in adults with atopic dermatitis; the study is currently…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Novartis is conducting a Phase 2 platform study to evaluate investigational compounds for moderate to severe atopic dermatitis, and the tria…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Topical Treatment for Atopic Dermatitis [NA]
A topical treatment for atopic dermatitis is currently recruiting, according to a clinical trial record.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis [Phase 1]
A Phase 1/1b clinical trial is evaluating the safety, tolerability and pharmacokinetics of ZL-1503 in healthy volunteers and adults with mod…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis [Phase 1]
Phase 1 clinical trial update describing safety and pharmacokinetics evaluation of LPX-TI641 in adults with atopic dermatitis and psoriasis.…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of ruxolitinib cream in children and adolescents aged 6 to <18 with moderate …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 clinical trial update assessing the long-term safety and efficacy of Lebrikizumab (LY3650150) in participants aged 6 months to under…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating drug candidate 611 for moderate-to-severe atopic dermatitis in Chinese children and adolescents is cur…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function [NA]
This clinical trial is evaluating whether a partially hydrolyzed formula with synbiotics affects skin barrier function in individuals with a…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
This clinical trial update describes an observational retrospective cohort study in pregnant women with atopic dermatitis, comparing exposur…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
A clinical trial is recruiting to compare maternal, fetal, and infant outcomes in pregnant women with mild to moderate atopic dermatitis exp…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults [NA]
A clinical trial update describes testing ivarmacitinib for moderate-to-severe Atopic Dermatitis in adolescents and adults, with the study c…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
Pfizer is recruiting participants for a study of Cibinqo (abrocitinib) in adults with atopic dermatitis to learn more about the study medica…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Pfizer is conducting a clinical study to evaluate abrocitinib in adults with moderate to severe atopic dermatitis, and the trial is currentl…